Global Pioglitazone Hydrochloride Capsules Market Growth 2026-2032

June 2026 | 90 pages | ID: G440C8E9B7A0EN
LP Information

Abstracts

The global Pioglitazone Hydrochloride Capsules market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

Pioglitazone hydrochloride capsules are effective hypoglycemic drugs that controls blood sugar levels by increasing the sensitivity of insulin receptors in the periphery and liver. They are mainly used for blood sugar control in type 2 diabetes and can only play a hypoglycemic role in the presence of insulin.

United States market for Pioglitazone Hydrochloride Capsules is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Pioglitazone Hydrochloride Capsules is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Pioglitazone Hydrochloride Capsules is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Pioglitazone Hydrochloride Capsules players cover Sandoz, Takeda Pharmaceuticals, Sichuan Luye Pharmaceutical Industry, Luote Group, Shandong Xinhua Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LP Information, Inc. (LPI) ' newest research report, the ?Pioglitazone Hydrochloride Capsules Industry Forecast? looks at past sales and reviews total world Pioglitazone Hydrochloride Capsules sales in 2025, providing a comprehensive analysis by region and market sector of projected Pioglitazone Hydrochloride Capsules sales for 2026 through 2032. With Pioglitazone Hydrochloride Capsules sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pioglitazone Hydrochloride Capsules industry.

This Insight Report provides a comprehensive analysis of the global Pioglitazone Hydrochloride Capsules landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pioglitazone Hydrochloride Capsules portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Pioglitazone Hydrochloride Capsules market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pioglitazone Hydrochloride Capsules and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pioglitazone Hydrochloride Capsules.

This report presents a comprehensive overview, market shares, and growth opportunities of Pioglitazone Hydrochloride Capsules market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• 15mg
• 30mg

Segmentation by Application:

• Hospital and Clinic
• Pharmacy

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Sandoz
• Takeda Pharmaceuticals
• Sichuan Luye Pharmaceutical Industry
• Luote Group
• Shandong Xinhua Pharmaceutical
• Northeast Pharmaceutical Group
• Hangzhou Zhongmeihuadong Pharmaceutical Jiangdong

Key Questions Addressed in this Report
What is the 10-year outlook for the global Pioglitazone Hydrochloride Capsules market?
What factors are driving Pioglitazone Hydrochloride Capsules market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pioglitazone Hydrochloride Capsules market opportunities vary by end market size?
How does Pioglitazone Hydrochloride Capsules break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Pioglitazone Hydrochloride Capsules Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for Pioglitazone Hydrochloride Capsules by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for Pioglitazone Hydrochloride Capsules by Country/Region, 2021, 2025 & 2032
2.2 Pioglitazone Hydrochloride Capsules Segment by Type
  2.2.1 15mg
  2.2.2 30mg
  2.2.3 Pioglitazone Hydrochloride Capsules Sales by Type
    2.2.3.1 Global Pioglitazone Hydrochloride Capsules Sales Market Share by Type (2021-2026)
    2.2.3.2 Global Pioglitazone Hydrochloride Capsules Revenue and Market Share by Type (2021-2026)
    2.2.3.3 Global Pioglitazone Hydrochloride Capsules Sale Price by Type (2021-2026)
2.3 Pioglitazone Hydrochloride Capsules Segment by Application
  2.3.1 Hospital and Clinic
  2.3.2 Pharmacy
  2.3.3 Pioglitazone Hydrochloride Capsules Sales by Application
    2.3.3.1 Global Pioglitazone Hydrochloride Capsules Sale Market Share by Application (2021-2026)
    2.3.3.2 Global Pioglitazone Hydrochloride Capsules Revenue and Market Share by Application (2021-2026)
    2.3.3.3 Global Pioglitazone Hydrochloride Capsules Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

3.1 Global Pioglitazone Hydrochloride Capsules Breakdown Data by Company
  3.1.1 Global Pioglitazone Hydrochloride Capsules Annual Sales by Company (2021-2026)
  3.1.2 Global Pioglitazone Hydrochloride Capsules Sales Market Share by Company (2021-2026)
3.2 Global Pioglitazone Hydrochloride Capsules Annual Revenue by Company (2021-2026)
  3.2.1 Global Pioglitazone Hydrochloride Capsules Revenue by Company (2021-2026)
  3.2.2 Global Pioglitazone Hydrochloride Capsules Revenue Market Share by Company (2021-2026)
3.3 Global Pioglitazone Hydrochloride Capsules Sale Price by Company
3.4 Key Manufacturers Pioglitazone Hydrochloride Capsules Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Pioglitazone Hydrochloride Capsules Product Location Distribution
  3.4.2 Players Pioglitazone Hydrochloride Capsules Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR PIOGLITAZONE HYDROCHLORIDE CAPSULES BY GEOGRAPHIC REGION

4.1 World Historic Pioglitazone Hydrochloride Capsules Market Size by Geographic Region (2021-2026)
  4.1.1 Global Pioglitazone Hydrochloride Capsules Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global Pioglitazone Hydrochloride Capsules Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Pioglitazone Hydrochloride Capsules Market Size by Country/Region (2021-2026)
  4.2.1 Global Pioglitazone Hydrochloride Capsules Annual Sales by Country/Region (2021-2026)
  4.2.2 Global Pioglitazone Hydrochloride Capsules Annual Revenue by Country/Region (2021-2026)
4.3 Americas Pioglitazone Hydrochloride Capsules Sales Growth
4.4 APAC Pioglitazone Hydrochloride Capsules Sales Growth
4.5 Europe Pioglitazone Hydrochloride Capsules Sales Growth
4.6 Middle East & Africa Pioglitazone Hydrochloride Capsules Sales Growth

5 AMERICAS

5.1 Americas Pioglitazone Hydrochloride Capsules Sales by Country
  5.1.1 Americas Pioglitazone Hydrochloride Capsules Sales by Country (2021-2026)
  5.1.2 Americas Pioglitazone Hydrochloride Capsules Revenue by Country (2021-2026)
5.2 Americas Pioglitazone Hydrochloride Capsules Sales by Type (2021-2026)
5.3 Americas Pioglitazone Hydrochloride Capsules Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Pioglitazone Hydrochloride Capsules Sales by Region
  6.1.1 APAC Pioglitazone Hydrochloride Capsules Sales by Region (2021-2026)
  6.1.2 APAC Pioglitazone Hydrochloride Capsules Revenue by Region (2021-2026)
6.2 APAC Pioglitazone Hydrochloride Capsules Sales by Type (2021-2026)
6.3 APAC Pioglitazone Hydrochloride Capsules Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Pioglitazone Hydrochloride Capsules by Country
  7.1.1 Europe Pioglitazone Hydrochloride Capsules Sales by Country (2021-2026)
  7.1.2 Europe Pioglitazone Hydrochloride Capsules Revenue by Country (2021-2026)
7.2 Europe Pioglitazone Hydrochloride Capsules Sales by Type (2021-2026)
7.3 Europe Pioglitazone Hydrochloride Capsules Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Pioglitazone Hydrochloride Capsules by Country
  8.1.1 Middle East & Africa Pioglitazone Hydrochloride Capsules Sales by Country (2021-2026)
  8.1.2 Middle East & Africa Pioglitazone Hydrochloride Capsules Revenue by Country (2021-2026)
8.2 Middle East & Africa Pioglitazone Hydrochloride Capsules Sales by Type (2021-2026)
8.3 Middle East & Africa Pioglitazone Hydrochloride Capsules Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pioglitazone Hydrochloride Capsules
10.3 Manufacturing Process Analysis of Pioglitazone Hydrochloride Capsules
10.4 Industry Chain Structure of Pioglitazone Hydrochloride Capsules

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Pioglitazone Hydrochloride Capsules Distributors
11.3 Pioglitazone Hydrochloride Capsules Customer

12 WORLD FORECAST REVIEW FOR PIOGLITAZONE HYDROCHLORIDE CAPSULES BY GEOGRAPHIC REGION

12.1 Global Pioglitazone Hydrochloride Capsules Market Size Forecast by Region
  12.1.1 Global Pioglitazone Hydrochloride Capsules Forecast by Region (2027-2032)
  12.1.2 Global Pioglitazone Hydrochloride Capsules Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Pioglitazone Hydrochloride Capsules Forecast by Type (2027-2032)
12.7 Global Pioglitazone Hydrochloride Capsules Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

13.1 Sandoz
  13.1.1 Sandoz Company Information
  13.1.2 Sandoz Pioglitazone Hydrochloride Capsules Product Portfolios and Specifications
  13.1.3 Sandoz Pioglitazone Hydrochloride Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 Sandoz Main Business Overview
  13.1.5 Sandoz Latest Developments
13.2 Takeda Pharmaceuticals
  13.2.1 Takeda Pharmaceuticals Company Information
  13.2.2 Takeda Pharmaceuticals Pioglitazone Hydrochloride Capsules Product Portfolios and Specifications
  13.2.3 Takeda Pharmaceuticals Pioglitazone Hydrochloride Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  13.2.4 Takeda Pharmaceuticals Main Business Overview
  13.2.5 Takeda Pharmaceuticals Latest Developments
13.3 Sichuan Luye Pharmaceutical Industry
  13.3.1 Sichuan Luye Pharmaceutical Industry Company Information
  13.3.2 Sichuan Luye Pharmaceutical Industry Pioglitazone Hydrochloride Capsules Product Portfolios and Specifications
  13.3.3 Sichuan Luye Pharmaceutical Industry Pioglitazone Hydrochloride Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  13.3.4 Sichuan Luye Pharmaceutical Industry Main Business Overview
  13.3.5 Sichuan Luye Pharmaceutical Industry Latest Developments
13.4 Luote Group
  13.4.1 Luote Group Company Information
  13.4.2 Luote Group Pioglitazone Hydrochloride Capsules Product Portfolios and Specifications
  13.4.3 Luote Group Pioglitazone Hydrochloride Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  13.4.4 Luote Group Main Business Overview
  13.4.5 Luote Group Latest Developments
13.5 Shandong Xinhua Pharmaceutical
  13.5.1 Shandong Xinhua Pharmaceutical Company Information
  13.5.2 Shandong Xinhua Pharmaceutical Pioglitazone Hydrochloride Capsules Product Portfolios and Specifications
  13.5.3 Shandong Xinhua Pharmaceutical Pioglitazone Hydrochloride Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  13.5.4 Shandong Xinhua Pharmaceutical Main Business Overview
  13.5.5 Shandong Xinhua Pharmaceutical Latest Developments
13.6 Northeast Pharmaceutical Group
  13.6.1 Northeast Pharmaceutical Group Company Information
  13.6.2 Northeast Pharmaceutical Group Pioglitazone Hydrochloride Capsules Product Portfolios and Specifications
  13.6.3 Northeast Pharmaceutical Group Pioglitazone Hydrochloride Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  13.6.4 Northeast Pharmaceutical Group Main Business Overview
  13.6.5 Northeast Pharmaceutical Group Latest Developments
13.7 Hangzhou Zhongmeihuadong Pharmaceutical Jiangdong
  13.7.1 Hangzhou Zhongmeihuadong Pharmaceutical Jiangdong Company Information
  13.7.2 Hangzhou Zhongmeihuadong Pharmaceutical Jiangdong Pioglitazone Hydrochloride Capsules Product Portfolios and Specifications
  13.7.3 Hangzhou Zhongmeihuadong Pharmaceutical Jiangdong Pioglitazone Hydrochloride Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  13.7.4 Hangzhou Zhongmeihuadong Pharmaceutical Jiangdong Main Business Overview
  13.7.5 Hangzhou Zhongmeihuadong Pharmaceutical Jiangdong Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Pioglitazone Hydrochloride Capsules Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Pioglitazone Hydrochloride Capsules Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 15mg
Table 4. Major Players of 30mg
Table 5. Global Pioglitazone Hydrochloride Capsules Sales by Type (2021-2026) & (K Units)
Table 6. Global Pioglitazone Hydrochloride Capsules Sales Market Share by Type (2021-2026)
Table 7. Global Pioglitazone Hydrochloride Capsules Revenue by Type (2021-2026) & ($ million)
Table 8. Global Pioglitazone Hydrochloride Capsules Revenue Market Share by Type (2021-2026)
Table 9. Global Pioglitazone Hydrochloride Capsules Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Pioglitazone Hydrochloride Capsules Sale by Application (2021-2026) & (K Units)
Table 11. Global Pioglitazone Hydrochloride Capsules Sale Market Share by Application (2021-2026)
Table 12. Global Pioglitazone Hydrochloride Capsules Revenue by Application (2021-2026) & ($ million)
Table 13. Global Pioglitazone Hydrochloride Capsules Revenue Market Share by Application (2021-2026)
Table 14. Global Pioglitazone Hydrochloride Capsules Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Pioglitazone Hydrochloride Capsules Sales by Company (2021-2026) & (K Units)
Table 16. Global Pioglitazone Hydrochloride Capsules Sales Market Share by Company (2021-2026)
Table 17. Global Pioglitazone Hydrochloride Capsules Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Pioglitazone Hydrochloride Capsules Revenue Market Share by Company (2021-2026)
Table 19. Global Pioglitazone Hydrochloride Capsules Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Pioglitazone Hydrochloride Capsules Producing Area Distribution and Sales Area
Table 21. Players Pioglitazone Hydrochloride Capsules Products Offered
Table 22. Pioglitazone Hydrochloride Capsules Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Pioglitazone Hydrochloride Capsules Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Pioglitazone Hydrochloride Capsules Sales Market Share Geographic Region (2021-2026)
Table 27. Global Pioglitazone Hydrochloride Capsules Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Pioglitazone Hydrochloride Capsules Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Pioglitazone Hydrochloride Capsules Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Pioglitazone Hydrochloride Capsules Sales Market Share by Country/Region (2021-2026)
Table 31. Global Pioglitazone Hydrochloride Capsules Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Pioglitazone Hydrochloride Capsules Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Pioglitazone Hydrochloride Capsules Sales by Country (2021-2026) & (K Units)
Table 34. Americas Pioglitazone Hydrochloride Capsules Sales Market Share by Country (2021-2026)
Table 35. Americas Pioglitazone Hydrochloride Capsules Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Pioglitazone Hydrochloride Capsules Sales by Type (2021-2026) & (K Units)
Table 37. Americas Pioglitazone Hydrochloride Capsules Sales by Application (2021-2026) & (K Units)
Table 38. APAC Pioglitazone Hydrochloride Capsules Sales by Region (2021-2026) & (K Units)
Table 39. APAC Pioglitazone Hydrochloride Capsules Sales Market Share by Region (2021-2026)
Table 40. APAC Pioglitazone Hydrochloride Capsules Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Pioglitazone Hydrochloride Capsules Sales by Type (2021-2026) & (K Units)
Table 42. APAC Pioglitazone Hydrochloride Capsules Sales by Application (2021-2026) & (K Units)
Table 43. Europe Pioglitazone Hydrochloride Capsules Sales by Country (2021-2026) & (K Units)
Table 44. Europe Pioglitazone Hydrochloride Capsules Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Pioglitazone Hydrochloride Capsules Sales by Type (2021-2026) & (K Units)
Table 46. Europe Pioglitazone Hydrochloride Capsules Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Pioglitazone Hydrochloride Capsules Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Pioglitazone Hydrochloride Capsules Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Pioglitazone Hydrochloride Capsules Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Pioglitazone Hydrochloride Capsules Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Pioglitazone Hydrochloride Capsules
Table 52. Key Market Challenges & Risks of Pioglitazone Hydrochloride Capsules
Table 53. Key Industry Trends of Pioglitazone Hydrochloride Capsules
Table 54. Pioglitazone Hydrochloride Capsules Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Pioglitazone Hydrochloride Capsules Distributors List
Table 57. Pioglitazone Hydrochloride Capsules Customer List
Table 58. Global Pioglitazone Hydrochloride Capsules Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Pioglitazone Hydrochloride Capsules Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Pioglitazone Hydrochloride Capsules Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Pioglitazone Hydrochloride Capsules Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Pioglitazone Hydrochloride Capsules Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Pioglitazone Hydrochloride Capsules Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Pioglitazone Hydrochloride Capsules Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Pioglitazone Hydrochloride Capsules Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Pioglitazone Hydrochloride Capsules Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Pioglitazone Hydrochloride Capsules Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Pioglitazone Hydrochloride Capsules Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Pioglitazone Hydrochloride Capsules Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Pioglitazone Hydrochloride Capsules Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Pioglitazone Hydrochloride Capsules Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Sandoz Basic Information, Pioglitazone Hydrochloride Capsules Manufacturing Base, Sales Area and Its Competitors
Table 73. Sandoz Pioglitazone Hydrochloride Capsules Product Portfolios and Specifications
Table 74. Sandoz Pioglitazone Hydrochloride Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Sandoz Main Business
Table 76. Sandoz Latest Developments
Table 77. Takeda Pharmaceuticals Basic Information, Pioglitazone Hydrochloride Capsules Manufacturing Base, Sales Area and Its Competitors
Table 78. Takeda Pharmaceuticals Pioglitazone Hydrochloride Capsules Product Portfolios and Specifications
Table 79. Takeda Pharmaceuticals Pioglitazone Hydrochloride Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Takeda Pharmaceuticals Main Business
Table 81. Takeda Pharmaceuticals Latest Developments
Table 82. Sichuan Luye Pharmaceutical Industry Basic Information, Pioglitazone Hydrochloride Capsules Manufacturing Base, Sales Area and Its Competitors
Table 83. Sichuan Luye Pharmaceutical Industry Pioglitazone Hydrochloride Capsules Product Portfolios and Specifications
Table 84. Sichuan Luye Pharmaceutical Industry Pioglitazone Hydrochloride Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Sichuan Luye Pharmaceutical Industry Main Business
Table 86. Sichuan Luye Pharmaceutical Industry Latest Developments
Table 87. Luote Group Basic Information, Pioglitazone Hydrochloride Capsules Manufacturing Base, Sales Area and Its Competitors
Table 88. Luote Group Pioglitazone Hydrochloride Capsules Product Portfolios and Specifications
Table 89. Luote Group Pioglitazone Hydrochloride Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Luote Group Main Business
Table 91. Luote Group Latest Developments
Table 92. Shandong Xinhua Pharmaceutical Basic Information, Pioglitazone Hydrochloride Capsules Manufacturing Base, Sales Area and Its Competitors
Table 93. Shandong Xinhua Pharmaceutical Pioglitazone Hydrochloride Capsules Product Portfolios and Specifications
Table 94. Shandong Xinhua Pharmaceutical Pioglitazone Hydrochloride Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Shandong Xinhua Pharmaceutical Main Business
Table 96. Shandong Xinhua Pharmaceutical Latest Developments
Table 97. Northeast Pharmaceutical Group Basic Information, Pioglitazone Hydrochloride Capsules Manufacturing Base, Sales Area and Its Competitors
Table 98. Northeast Pharmaceutical Group Pioglitazone Hydrochloride Capsules Product Portfolios and Specifications
Table 99. Northeast Pharmaceutical Group Pioglitazone Hydrochloride Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Northeast Pharmaceutical Group Main Business
Table 101. Northeast Pharmaceutical Group Latest Developments
Table 102. Hangzhou Zhongmeihuadong Pharmaceutical Jiangdong Basic Information, Pioglitazone Hydrochloride Capsules Manufacturing Base, Sales Area and Its Competitors
Table 103. Hangzhou Zhongmeihuadong Pharmaceutical Jiangdong Pioglitazone Hydrochloride Capsules Product Portfolios and Specifications
Table 104. Hangzhou Zhongmeihuadong Pharmaceutical Jiangdong Pioglitazone Hydrochloride Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Hangzhou Zhongmeihuadong Pharmaceutical Jiangdong Main Business
Table 106. Hangzhou Zhongmeihuadong Pharmaceutical Jiangdong Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Pioglitazone Hydrochloride Capsules
Figure 2. Pioglitazone Hydrochloride Capsules Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pioglitazone Hydrochloride Capsules Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Pioglitazone Hydrochloride Capsules Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Pioglitazone Hydrochloride Capsules Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Pioglitazone Hydrochloride Capsules Sales Market Share by Country/Region (2025)
Figure 10. Pioglitazone Hydrochloride Capsules Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 15mg
Figure 12. Product Picture of 30mg
Figure 13. Global Pioglitazone Hydrochloride Capsules Sales Market Share by Type in 2026
Figure 14. Global Pioglitazone Hydrochloride Capsules Revenue Market Share by Type (2021-2026)
Figure 15. Pioglitazone Hydrochloride Capsules Consumed in Hospital and Clinic
Figure 16. Global Pioglitazone Hydrochloride Capsules Market: Hospital and Clinic (2021-2026) & (K Units)
Figure 17. Pioglitazone Hydrochloride Capsules Consumed in Pharmacy
Figure 18. Global Pioglitazone Hydrochloride Capsules Market: Pharmacy (2021-2026) & (K Units)
Figure 19. Global Pioglitazone Hydrochloride Capsules Sale Market Share by Application (2025)
Figure 20. Global Pioglitazone Hydrochloride Capsules Revenue Market Share by Application in 2026
Figure 21. Pioglitazone Hydrochloride Capsules Sales by Company in 2026 (K Units)
Figure 22. Global Pioglitazone Hydrochloride Capsules Sales Market Share by Company in 2026
Figure 23. Pioglitazone Hydrochloride Capsules Revenue by Company in 2026 ($ millions)
Figure 24. Global Pioglitazone Hydrochloride Capsules Revenue Market Share by Company in 2026
Figure 25. Global Pioglitazone Hydrochloride Capsules Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global Pioglitazone Hydrochloride Capsules Revenue Market Share by Geographic Region in 2026
Figure 27. Americas Pioglitazone Hydrochloride Capsules Sales 2021-2026 (K Units)
Figure 28. Americas Pioglitazone Hydrochloride Capsules Revenue 2021-2026 ($ millions)
Figure 29. APAC Pioglitazone Hydrochloride Capsules Sales 2021-2026 (K Units)
Figure 30. APAC Pioglitazone Hydrochloride Capsules Revenue 2021-2026 ($ millions)
Figure 31. Europe Pioglitazone Hydrochloride Capsules Sales 2021-2026 (K Units)
Figure 32. Europe Pioglitazone Hydrochloride Capsules Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa Pioglitazone Hydrochloride Capsules Sales 2021-2026 (K Units)
Figure 34. Middle East & Africa Pioglitazone Hydrochloride Capsules Revenue 2021-2026 ($ millions)
Figure 35. Americas Pioglitazone Hydrochloride Capsules Sales Market Share by Country in 2026
Figure 36. Americas Pioglitazone Hydrochloride Capsules Revenue Market Share by Country (2021-2026)
Figure 37. Americas Pioglitazone Hydrochloride Capsules Sales Market Share by Type (2021-2026)
Figure 38. Americas Pioglitazone Hydrochloride Capsules Sales Market Share by Application (2021-2026)
Figure 39. United States Pioglitazone Hydrochloride Capsules Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada Pioglitazone Hydrochloride Capsules Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico Pioglitazone Hydrochloride Capsules Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil Pioglitazone Hydrochloride Capsules Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC Pioglitazone Hydrochloride Capsules Sales Market Share by Region in 2026
Figure 44. APAC Pioglitazone Hydrochloride Capsules Revenue Market Share by Region (2021-2026)
Figure 45. APAC Pioglitazone Hydrochloride Capsules Sales Market Share by Type (2021-2026)
Figure 46. APAC Pioglitazone Hydrochloride Capsules Sales Market Share by Application (2021-2026)
Figure 47. China Pioglitazone Hydrochloride Capsules Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan Pioglitazone Hydrochloride Capsules Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea Pioglitazone Hydrochloride Capsules Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia Pioglitazone Hydrochloride Capsules Revenue Growth 2021-2026 ($ millions)
Figure 51. India Pioglitazone Hydrochloride Capsules Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia Pioglitazone Hydrochloride Capsules Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan Pioglitazone Hydrochloride Capsules Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe Pioglitazone Hydrochloride Capsules Sales Market Share by Country in 2026
Figure 55. Europe Pioglitazone Hydrochloride Capsules Revenue Market Share by Country (2021-2026)
Figure 56. Europe Pioglitazone Hydrochloride Capsules Sales Market Share by Type (2021-2026)
Figure 57. Europe Pioglitazone Hydrochloride Capsules Sales Market Share by Application (2021-2026)
Figure 58. Germany Pioglitazone Hydrochloride Capsules Revenue Growth 2021-2026 ($ millions)
Figure 59. France Pioglitazone Hydrochloride Capsules Revenue Growth 2021-2026 ($ millions)
Figure 60. UK Pioglitazone Hydrochloride Capsules Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy Pioglitazone Hydrochloride Capsules Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia Pioglitazone Hydrochloride Capsules Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa Pioglitazone Hydrochloride Capsules Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa Pioglitazone Hydrochloride Capsules Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa Pioglitazone Hydrochloride Capsules Sales Market Share by Application (2021-2026)
Figure 66. Egypt Pioglitazone Hydrochloride Capsules Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa Pioglitazone Hydrochloride Capsules Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel Pioglitazone Hydrochloride Capsules Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey Pioglitazone Hydrochloride Capsules Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries Pioglitazone Hydrochloride Capsules Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Pioglitazone Hydrochloride Capsules in 2026
Figure 72. Manufacturing Process Analysis of Pioglitazone Hydrochloride Capsules
Figure 73. Industry Chain Structure of Pioglitazone Hydrochloride Capsules
Figure 74. Channels of Distribution
Figure 75. Global Pioglitazone Hydrochloride Capsules Sales Market Forecast by Region (2027-2032)
Figure 76. Global Pioglitazone Hydrochloride Capsules Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global Pioglitazone Hydrochloride Capsules Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global Pioglitazone Hydrochloride Capsules Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global Pioglitazone Hydrochloride Capsules Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global Pioglitazone Hydrochloride Capsules Revenue Market Share Forecast by Application (2027-2032)